Skip to content

Dolby Laboratories, Inc. DLB Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)

Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year) at other companies

Applied Materials logo
Applied MaterialsAMAT

Other financials

Income statement

See full
Revenue$395.6M+7.1%
Gross profit$350.9M+5.1%
Operating income$112.9M+4.8%
Net income$94.9M+3.4%
EPS (diluted)$0.99+5.3%

Balance sheet

See full
Cash & equivalents$673.8M-10.2%
Total debt$49.7M+22.9%
Total equity$2.6B+1.7%
Total assets$3.2B+0.6%

Cash flow

See full
Operating cash flow$92.5M-47.1%
CapEx$9.1M+31.4%
Free cash flow$83.4M-50.3%

Valuation

See full
Market cap$4.95B-25.9%

Profitability

See full
Gross margin87.4%-1.5pp
Operating margin18.5%-2.0pp
Net margin17.9%-1.6pp
FCF margin22.1%-7.5pp

Returns & leverage

See full
Return on equity9.4%-0.9pp
Debt / equity0.0×
Current ratio-0.1×

Where this comes from

Reported directly by Dolby Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost.

The official record: Dolby Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dolby Laboratories, Inc.'s available-for-sale debt securities - amortized cost (due within one year).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dolby Laboratories, Inc.'s available-for-sale debt securities - amortized cost (due within one year)?
Dolby Laboratories, Inc. (DLB) reported available-for-sale debt securities - amortized cost (due within one year) of $1.29M in Q1 2026.
How has Dolby Laboratories, Inc.'s available-for-sale debt securities - amortized cost (due within one year) changed year-over-year?
Dolby Laboratories, Inc.'s available-for-sale debt securities - amortized cost (due within one year) increased by 131.9% year-over-year, from $558K to $1.29M.
What is the long-term trend for Dolby Laboratories, Inc.'s available-for-sale debt securities - amortized cost (due within one year)?
Over 4 years (2020 to 2025), Dolby Laboratories, Inc.'s available-for-sale debt securities - amortized cost (due within one year) has grown at a -9.9% compound annual growth rate (CAGR), from $261.84M to $172.47M.